全文获取类型
收费全文 | 103584篇 |
免费 | 6147篇 |
国内免费 | 1997篇 |
专业分类
耳鼻咽喉 | 569篇 |
儿科学 | 3125篇 |
妇产科学 | 1496篇 |
基础医学 | 10165篇 |
口腔科学 | 1689篇 |
临床医学 | 9089篇 |
内科学 | 13988篇 |
皮肤病学 | 719篇 |
神经病学 | 10361篇 |
特种医学 | 3030篇 |
外国民族医学 | 2篇 |
外科学 | 10097篇 |
综合类 | 14942篇 |
现状与发展 | 7篇 |
一般理论 | 4篇 |
预防医学 | 16189篇 |
眼科学 | 1229篇 |
药学 | 9180篇 |
115篇 | |
中国医学 | 2725篇 |
肿瘤学 | 3007篇 |
出版年
2023年 | 1265篇 |
2022年 | 2276篇 |
2021年 | 3585篇 |
2020年 | 3223篇 |
2019年 | 5651篇 |
2018年 | 4840篇 |
2017年 | 3402篇 |
2016年 | 2672篇 |
2015年 | 2714篇 |
2014年 | 5822篇 |
2013年 | 6077篇 |
2012年 | 5482篇 |
2011年 | 5920篇 |
2010年 | 4703篇 |
2009年 | 4358篇 |
2008年 | 4453篇 |
2007年 | 4145篇 |
2006年 | 3666篇 |
2005年 | 3184篇 |
2004年 | 2629篇 |
2003年 | 2322篇 |
2002年 | 1789篇 |
2001年 | 1544篇 |
2000年 | 1301篇 |
1999年 | 1086篇 |
1998年 | 1065篇 |
1997年 | 1041篇 |
1996年 | 833篇 |
1995年 | 763篇 |
1994年 | 742篇 |
1993年 | 624篇 |
1992年 | 591篇 |
1991年 | 583篇 |
1990年 | 460篇 |
1989年 | 420篇 |
1988年 | 429篇 |
1987年 | 404篇 |
1985年 | 1457篇 |
1984年 | 1815篇 |
1983年 | 1314篇 |
1982年 | 1420篇 |
1981年 | 1347篇 |
1980年 | 1193篇 |
1979年 | 1211篇 |
1978年 | 1130篇 |
1977年 | 813篇 |
1976年 | 975篇 |
1975年 | 827篇 |
1974年 | 748篇 |
1973年 | 774篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
93.
94.
目的:探讨醛-酮还原酶家族7成员A3(AKR7A3)在肺腺癌中的异常表达及与临床病理特征的关系,并探究其临床意义。方法:采用生物信息学数据库分析、免疫组化、Western Blot、Real-time PCR等方法对肺腺癌组织及不同细胞中AKR7A3的表达进行检测与分析。结果:Oncomine数据库分析结果显示,在肺腺癌中,AKR7A3的表达普遍高于正常肺组织,分别为正常肺组织的1.811倍(P=0.022)、1.356倍(P<0.01)、1.413倍(P=0.002)。Kaplan-Meier Plotter数据库分析结果显示,AKR7A3高表达的患者较低表达的患者生存时间缩短,差异具有统计学意义(P=0.003 7)。免疫组化染色显示肺腺癌组织中AKR7A3的表达较癌旁增高,在与临床病理特征的相关性分析中,发现其与肿瘤分化程度(P<0.01)、淋巴结转移情况(P=0.029)以及TNM分期(P<0.01)相关,且会造成患者生存时间缩短(P=0.031)。Cox多因素分析表明AKR7A3可能是影响肺腺癌患者预后的独立危险因素(P=0.012)。Western Blot及Real-time PCR实验提示不同肺腺癌细胞中AKR7A3蛋白及mRNA表达普遍增高。结论:AKR7A3在肺腺癌中表达增高,对预后有不良影响,有促进肿瘤发生发展的作用。 相似文献
95.
96.
97.
98.
99.
Shinji Naganawa Rintaro Ito Hisashi Kawai Toshiaki Taoka Tadao Yoshida Michihiko Sone 《Magnetic resonance in medical sciences》2020,19(4):375
Purpose:It has been reported previously that intravenously administered gadolinium-based contrast agent (GBCA) leaks into the subarachnoid space around the cortical veins at 4 h after injection in all old people over 37 years, but not in younger people up to 37 years of age in 3D-real IR images. The purpose of this study was to investigate whether there was a strict threshold of 37 years of age for the leakage of the GBCA into the subarachnoid space.Methods:The subjects included 190 patients, that were scanned for 3D-real IR images at 4 hours after intravenous injection of GBCA as a diagnostic test for endolymphatic hydrops. The patient’s age ranged from 14 to 81 years. Two experienced neuroradiologists evaluated the images to determine whether the GBCA leakage around the cortical veins was positive or negative. Any discrepancies between the two observers were discussed and a consensus was obtained.A Mann–Whitney U test and receiver operating characteristic (ROC) curve analysis were used to compare the positive and the negative group and to set the age cut-off value for the prediction of GBCA leakage.Results:The GBCA leakage around the cortical veins was negative in 35 patients and positive in 155 patients. The average age was 33 ± 11 years in the negative group, and 55 ± 12 years in the positive group (P < 0.01). In the ROC analysis for the age and leakage of the GBCA, an area under the curve was 0.905 and the cut-off age was 37.317 years (sensitivity of 0.942 and specificity of 0.771).Conclusion:Intravenously administered GBCA leaks into the subarachnoid space around the cortical veins in most patients over 37 years of age. However, it should be noted that it can be found occasionally in patients under 37 years of age. 相似文献
100.
ABSTRACT Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis. However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases. Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases. 相似文献